Yoshimitsu Yamasaki Selected Research

Yoshimitsu Yamasaki Research Topics

Disease

32	Type 2 Diabetes Mellitus (MODY) 04/2017 - 07/2002
24	Insulin Resistance 01/2009 - 01/2002
10	Atherosclerosis 02/2011 - 02/2003
9	Carotid Artery Diseases 01/2014 - 08/2002
6	Hypertension (High Blood Pressure) 01/2014 - 01/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2006
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2009 - 08/2002
5	Hyperglycemia 07/2007 - 02/2003
4	Abdominal Obesity 01/2013 - 03/2009
3	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2015 - 07/2008
3	Diabetes Complications 11/2011 - 09/2008
3	Glucose Intolerance 01/2009 - 01/2002
3	Diabetic Angiopathies (Diabetic Angiopathy) 07/2008 - 10/2005
2	Hyperkalemia 02/2021 - 04/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2017 - 01/2013
2	Albuminuria 04/2017 - 02/2011
2	Stroke (Strokes) 02/2014 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 02/2014 - 01/2004
2	Dyslipidemias (Dyslipidemia) 01/2014 - 08/2009
2	Cerebral Infarction 01/2014 - 01/2004
2	Edema (Dropsy) 12/2009 - 08/2008
2	Obesity 07/2007 - 11/2004
1	Chronic Disease (Chronic Diseases) 02/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013
1	IGA Glomerulonephritis (IGA Nephropathy) 03/2012
1	Coronary Disease (Coronary Heart Disease) 11/2011
1	Peripheral Arterial Disease 06/2010
1	Myocardial Infarction 05/2010
1	Isolated Systolic Hypertension 08/2009
1	Infections 08/2008
1	Pleural Effusion (Pleural Effusions) 08/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2008
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2008
1	Body Weight (Weight, Body) 11/2007

Drug/Important Bio-Agent (IBA)

21	Glucose (Dextrose)FDA LinkGeneric 08/2008 - 01/2002
16	Insulin (Novolin)FDA Link 12/2009 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 02/2011 - 01/2004
5	Pioglitazone (Actos)FDA Link 01/2014 - 04/2007
5	Triglycerides (Triacylglycerol)IBA 01/2013 - 08/2009
5	HDL CholesterolIBA 01/2013 - 08/2009
4	AlbuminsIBA 01/2013 - 07/2008
3	CreatinineIBA 01/2013 - 12/2009
3	Oxygen (Dioxygen)IBA 05/2010 - 01/2005
3	Advanced Glycation End ProductsIBA 05/2009 - 11/2005
3	human esRAGE proteinIBA 05/2009 - 11/2005
3	Indicators and Reagents (Reagents)IBA 03/2009 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 07/2007 - 01/2005
3	JNK Mitogen-Activated Protein KinasesIBA 01/2006 - 10/2004
3	AntioxidantsIBA 11/2005 - 07/2002
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2015 - 07/2010
2	CopperIBA 01/2013 - 01/2009
2	LipidsIBA 01/2013 - 02/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 01/2009
2	AdiponectinIBA 02/2012 - 07/2007
2	oxidized low density lipoproteinIBA 02/2011 - 01/2002
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2010 - 08/2006
2	Cilostazol (Pletal)FDA LinkGeneric 06/2010 - 08/2006
2	1,2- diarachidonoyl- glycero- 3- phosphocholineIBA 06/2010 - 08/2006
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2010 - 08/2006
2	Pharmaceutical PreparationsIBA 08/2009 - 01/2004
2	Sucrose (Saccharose)IBA 01/2009 - 02/2008
2	Blood Glucose (Blood Sugar)IBA 07/2008 - 10/2004
2	Probucol (Lorelco)FDA Link 11/2005 - 07/2002
2	Molecular Chaperones (Chaperone, Molecular)IBA 03/2005 - 01/2005
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 02/2003 - 01/2002
2	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2003 - 01/2002
1	sodium zirconium cyclosilicateIBA 02/2021
1	CationsIBA 02/2021
1	PotassiumIBA 04/2017
1	finerenoneIBA 04/2017
1	Pravastatin (Pravachol)FDA LinkGeneric 02/2014
1	CholesterolIBA 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014
1	Peroxidase (Myeloperoxidase)IBA 01/2013
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 03/2012
1	LDL CholesterolIBA 11/2011
1	Glyburide (Glibenclamide)FDA LinkGeneric 04/2011
1	glimepiride (Amarel)FDA LinkGeneric 04/2011
1	Lipoproteins (Lipoprotein)IBA 02/2011
1	Monocyte Chemoattractant ProteinsIBA 07/2010
1	Phosphodiesterase InhibitorsIBA 06/2010
1	Antihypertensive Agents (Antihypertensives)IBA 08/2009
1	Chelating AgentsIBA 01/2009
1	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 01/2009
1	Glycated ProteinsIBA 07/2008
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2008
1	pigment epithelium-derived factorIBA 07/2008
1	Ointments (Pastes)IBA 03/2008
1	nafamostatIBA 03/2008
1	Green Fluorescent ProteinsIBA 02/2008
1	Keratins (Keratin)IBA 11/2007
1	Amylases FDA Link 11/2007
1	Glucagon (Glukagon)FDA Link 11/2007
1	N 30IBA 07/2007

Therapy/Procedure

8	Therapeutics 02/2021 - 06/2005
3	Glycemic Control 01/2013 - 07/2008
2	Secondary Prevention 01/2022 - 02/2014
1	Transplantation 08/2008
1	Kidney Transplantation 08/2008
1	Light Coagulation 01/2008